screen-shot-2019-02-24-at-5-13-58-pm-273x300-7656328At Thursday night’s Democratic presidential debate, Sen. Kirsten Gillibrand gave a misleading description of the “Medicare for all” proposal that she says she helped to write – implying that it calls for a voluntary buy-in rather than mandatory government coverage.

Gillibrand cosponsors Sen. Bernie Sanders’ Medicare for All Act of 2019, and describes herself as the author of the section dealing with the transition from the status quo to single payer. That bill does provide for an optional buy-in during a four-year transition period, but it would work differently than she described during the debate.

Here is what she said on stage in Miami:

In 2005, when I ran for Congress in a 2-1 Republican district, I actually ran on Medicare for All, and I won that 2-1 Republican district twice. And the way I formulated it was simple: Anyone who doesn’t have access to insurance they like, they could buy it in [at] a percentage of income they could afford. So, that’s what we put into the transition period for our Medicare for All plan. … The quickest way you get there is you create competition with the insurers. God bless the insurers if they want to compete; they can certainly try. But they’d never put people over their profits, and I doubt they ever will. So what will happen is people will choose Medicare. You will transition. We would get to Medicare for All. And then your step to single payer is so short. I would make it an earned benefit just like Social Security, so that you buy in your whole life. It is always there for you and it’s permanent and it’s universal.

This account differs from the bill language in important ways.

  • The buy-in would not be available to anyone who wants it. Applicants would have to be at least 55 years old in the first transition year, 45 in the second and 35 in the third. 
  • Buy-in premiums would not be based on a percentage of income, but on the program’s average projected cost per recipient. The net cost would be reduced for many enrollees through tax credits similar to those offered under the Affordable Care Act.
  • The buy-in period would be limited to three years. At the beginning of the fourth year, Americans would no longer “choose” to buy the federal plan. Enrollment would be automatic and universal.
  • Even if private insurers successfully competed with the federal plan, they would be effectively banned and put out of business at the end of the third year.

These inconsistencies raise doubts about where Gillibrand stands on a central issue for Democrats in the 2020 race – the role of private and employer-based insurance in the nation’s health-care system. Her debate statement implied that it would continue to be an option, but the legislation she touts says otherwise.

Another thorny issue is how much what she calls an “earned benefit” would ultimately cost for taxpayers. Gillibrand initially claimed the price tag would be just 4 percent of income, then clarified that employers would also have to contribute a similar amount. As discussed in previous posts, neither rate would come close to raising enough revenue for a single-payer system.

 

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

The Attorney General’s MFCU SNAFU

Attorney General Letitia James' latest fight with the Trump administration focuses on New York's Medicaid Fraud Control Unit, a federally funded agency housed in James' office. On T Read More

Healthcare Revelations in the Enacted Budget Financial Plan

The state financial plan published on June 10 disclosed key information about healthcare revenue and spending that lawmakers had not made public when approving the annual budget two weeks before. Read More

Federal Suit Traces Medicaid Fraud to the Top of NYS Government

The Trump administration's latest salvo against Medicaid fraud takes aim at a different kind of target – two high-ranking New York officials along with a major state contractor. A Read More

Healthcare Highlights in the New State Budget

Governor Hochul's focus on affordability seems to have skipped over the healthcare portions of the new state budget. The deal finalized May 27 Read More

Lawmakers Consider Hiking Fees for Filling Prescriptions

UPDATE: The proposal discussed below passed the Assembly Friday evening by an unofficial vote of 133-0. Having previously been approved by the Senate, the bill will head to Governor Hochul's desk for her signature or ve Read More

Budget Deal Reportedly Earmarks $100M for 1199 and Extends MCO Tax

As Governor Hochul and legislative leaders rush to finalize the overdue state budget, outlines of some healthcare-related deals have begun to emerge from the closed-door negotiations. Read More

Albany Wavers on Shutting Down a Medicaid Racket

As Washington threatens to crack down on fraud and abuse in New York's Medicaid program, state legislators are doing their best to demonstrate why federal intervention is needed. A Read More

Getting to the Bottom of the 340B Drug Discount Boondoggle

Some of New York's largest and most prosperous hospitals are reporting rapidly growing amounts of revenue from pharmacy sales – most of it apparently flowing from a controversial drug discount program known as 340B. Read More